| The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 600 (7890), 675-679, 2021 | 454 | 2021 |
| A saturated map of common genetic variants associated with human height L Yengo, S Vedantam, E Marouli, J Sidorenko, E Bartell, S Sakaue, ... Nature 610 (7933), 704-712, 2022 | 361 | 2022 |
| PTEN and PI3K/AKT in non-small-cell lung cancer C Pérez-Ramírez, M Cañadas-Garre, MÁ Molina, MJ Faus-Dáder, ... Pharmacogenomics 16 (16), 1843-1862, 2015 | 234 | 2015 |
| Genetic susceptibility to chronic kidney disease–some more pieces for the heritability puzzle M Cañadas-Garre, K Anderson, R Cappa, R Skelly, LJ Smyth, ... Frontiers in Genetics 10, 453, 2019 | 104 | 2019 |
| Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease TW Winkler, F Grassmann, C Brandl, C Kiel, F Günther, T Strunz, ... BMC medical genomics 13, 1-18, 2020 | 79 | 2020 |
| Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis JC Plaza-Plaza, M Aguilera, M Cañadas-Garre, C Chemello, ... Omics: a journal of integrative biology 16 (11), 589-595, 2012 | 76 | 2012 |
| Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis LJ Smyth, M Cañadas-Garre, RC Cappa, AP Maxwell, AJ McKnight BMJ open 9 (4), e026777, 2019 | 63 | 2019 |
| Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAFT1799A mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 … M Cañadas-Garre, P Becerra-Massare, ML de la Torre-Casares, ... Annals of surgery 255 (5), 986-992, 2012 | 55 | 2012 |
| Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease M Cañadas-Garre, K Anderson, J McGoldrick, AP Maxwell, AJ McKnight Journal of proteomics 193, 93-122, 2019 | 53 | 2019 |
| Diabetes-related neurological implications and pharmacogenomics CA Rojas-Carranza, RH Bustos-Cruz, CJ Pino-Pinzón, YV Ariza-Marquez, ... Current pharmaceutical design 24 (15), 1695-1710, 2018 | 52 | 2018 |
| Genomic approaches in the search for molecular biomarkers in chronic kidney disease M Cañadas-Garre, K Anderson, J McGoldrick, AP Maxwell, AJ McKnight Journal of translational medicine 16, 1-44, 2018 | 46 | 2018 |
| Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis M Maldonado-Montoro, M Cañadas-Garre, A González-Utrilla, ... Pharmacological research 111, 264-271, 2016 | 44 | 2016 |
| Liquid biopsy in early stage lung cancer C Pérez-Ramírez, M Cañadas-Garre, AI Robles, MÁ Molina, ... Translational lung cancer research 5 (5), 517, 2016 | 43 | 2016 |
| Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis M Maldonado-Montoro, M Cañadas-Garre, A González-Utrilla, ... The pharmacogenomics journal 18 (1), 167-172, 2018 | 41 | 2018 |
| Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer C Perez-Ramirez, M Canadas-Garre, MÁ Molina, AI Robles, ... Mutation Research/Reviews in Mutation Research 771, 32-58, 2017 | 41 | 2017 |
| Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals E Danese, S Raimondi, M Montagnana, A Tagetti, T Langaee, P Borgiani, ... Clinical Pharmacology & Therapeutics 105 (6), 1477-1491, 2019 | 38 | 2019 |
| Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients C Perez-Ramirez, M Canadas-Garre, A Alnatsha, E Villar, JR Delgado, ... Pharmacological research 111, 877-884, 2016 | 36 | 2016 |
| Pharmacogenetics role in the safety of acenocoumarol therapy E Jimenez-Varo, M Canadas-Garre, CI Henriques, AM Pinheiro, ... Thrombosis and haemostasis 112 (09), 522-536, 2014 | 32 | 2014 |
| Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients C Perez-Ramirez, M Canadas-Garre, A Alnatsha, E Villar, ... The pharmacogenomics journal 19 (2), 164-177, 2019 | 30 | 2019 |
| Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer C Perez-Ramirez, M Canadas-Garre, A Alnatsha, MÁ Molina, AI Robles, ... Surgical Oncology 26 (3), 278-285, 2017 | 28 | 2017 |
